Access
To read this story in full you will need to login or make a payment (see right).
Opinion
Nature 403, 687 (17 February 2000) | doi:10.1038/35001719
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Postdoctoral Position
- Fox Chase Cancer Center
- Philadelphia, Pennsylvania, United States, 19111
Professor of Microscopy (W2)
- Friedrich-Schiller-University
- Jena Germany
Science and more for TB
Top of page
Abstract
Traditional systems for developing drugs are failing spectacularly to deliver the goods in the fight against tuberculosis. Innovative public–private collaborations point the way forward.
The diseases that afflict the developing world defy the imagination in their scale. One third of the world's population — 2 billion people — are infected with Mycobacterium tuberculosis, and 16 million have active tuberculosis (TB).
To read this story in full you will need to login or make a payment (see right).
